KCNE4 Activators
KCNE4 Activators are a collection of chemical entities that improve the functional role of KCNE4 through indirect interactions with various signaling pathways. Isoproterenol, Forskolin, and Dibutyryl-cAMP augment the activity of KCNE4 by increasing intracellular cyclic AMP, thus activating PKA, which is known to phosphorylate proteins that could include KCNE4, thereby enhancing its regulatory influence on potassium channel activity. Similarly, PMA, as an activator of protein kinase C, may lead to phosphorylation events that strengthen the regulatory actions of KCNE4 on potassium channels. Anisomycin, through its stimulation of JNK pathways, is another agent that could indirectly potentiate the function of KCNE4 by modulating its state through stress-activated protein kinases, which are involved in various cellular responses, including ion channel regulation.
In the backdrop of altered ion currents, Adenosine's activation of adenosine receptors leading to PKA activation may further potentiate KCNE4 activity through phosphorylation mechanisms. The influence of Spironolactone on electrolyte balance could indirectly enhance KCNE4's modulation of potassium channels by impacting the ionic environment. Niflumic acid and ZD7288, by shifting chloride and hyperpolarization-activated cation currents respectively, could also enhance the regulatory actions of KCNE4 on potassium channel function. Cromakalim's activation of ATP-sensitive potassium channels might indirectly enhance KCNE4-mediated modulation by altering the membrane potential and influencing the dynamics of potassium channel activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts as a beta-adrenergic agonist to increase cyclic AMP levels within cells. Elevated cyclic AMP activates protein kinase A (PKA), which can phosphorylate and potentially enhance the activity of KCNE4 by modulating its interaction with voltage-gated potassium channels. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in cyclic AMP and activation of PKA. This cascade can phosphorylate various proteins, including KCNE4, thereby enhancing its function within potassium channel complexes. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that directly activates PKA. PKA can then enhance KCNE4 activity by phosphorylating the protein, affecting its regulatory role in potassium channel conductance. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can lead to the phosphorylation of proteins involved in ion channel regulation. KCNE4, as a potassium channel beta subunit, may have its activity enhanced through PKC-mediated signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a pyrrolidine antibiotic known to activate stress-activated protein kinases (SAPKs) including JNK. Activation of SAPKs can modulate ion channel function, thus potentially enhancing KCNE4 activity through post-translational modifications. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine activates adenosine receptors which are coupled to adenylyl cyclase via G proteins. The resultant increase in cyclic AMP may activate PKA, which could then phosphorylate KCNE4, modulating its regulatory effects on potassium channel activity. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone, through its action as an aldosterone antagonist, can influence electrolyte balance and indirectly affect ion channel function. This modulation of ionic environment may enhance the regulatory role of KCNE4 in potassium channel activity. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid is a chloride channel blocker that by altering chloride conductance may shift the electrochemical gradient and indirectly affect KCNE4's modulation of potassium channel activity. | ||||||
(±)-Cromakalim | 94470-67-4 | sc-217958 | 25 mg | $428.00 | ||
Cromakalim activates ATP-sensitive potassium channels. While primarily affecting these channels, the drug may indirectly enhance KCNE4 activity by altering membrane potential and the functional dynamics of voltage-gated potassium channels with which KCNE4 interacts. | ||||||